Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Frankfurt-listed (FRA: ADS) global #2 sportswear at €23.7B revenue with Boost running technology and three-stripe heritage; competing with Nike for athlete sponsorships and lifestyle footwear led by Samba and Gazelle.
Adidas AG is a Herzogenaurach, Germany-based global athletic footwear, apparel, and equipment company — the world's second-largest sportswear company by revenue — designing and manufacturing performance products for running, soccer, basketball, training, outdoor, and tennis, alongside lifestyle apparel and footwear collections under Adidas and Reebok (sold to Authentic Brands Group in 2021). Listed on Frankfurt Stock Exchange (FRA: ADS) and included in the DAX index, Adidas generated €23.7 billion in net revenue in fiscal year 2024, competing directly with Nike (NYSE: NKE, the global #1 at $51B revenue) for athlete sponsorships, retail shelf space, and consumer athletic purchase across 160+ countries.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.